Tandem Diabetes Care ( TNDM 4.25%) had some encouraging news to report on the regulatory front Thursday, and after it hit the ...

Tandem and Eli Lilly carried out trials to demonstrate the advantages of using Lyumjev in combination with Control-IQ ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...

Capital World Investors (Trades, Portfolio) executed a significant transaction by reducing their holdings in Tandem Diabetes ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNYNF – Research Report) and Tandem ...

An investigational once-weekly insulin was noninferior to a daily option for patients with type 2 diabetes, but proved risky ...

A recent study from Western Sydney University has shown that a simple change in how healthcare providers manage type 2 ...

Despite insufficient data, writing panel will give recommendations for preparation, transfer, and follow-up for youth with ...

A news release from the National Institutes of Health (NIH) said that, "scientists are not clear how metformin may prevent ...

Weight loss drugs have gained attention as a tool to help combat obesity, but understanding how they work, who they’re for, ...